Titan Pharmaceuticals, Inc. (TTNP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1,412.82 |
| Enterprise Value | -326,587 |
| P/E Ratio | -0 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 1.73 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 0.45 |
| Enterprise/EBITDA | 3.83 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.09 |
| Operating Margin | 0.07 |
| Return On Assets | 0.02 |
| Return On Equity | 0 |
| Revenue | 0 |
| Revenue/Share | 2,683.13 |
| Gross Profit | 0 |
| EBITDA | -2.42M |
| Net Income | -2.49M |
| Diluted EPS | -2,937.35 |
| Total Cash | 328,000 |
| Total Cash/Share | 3,932.48 |
| Total Debt | 0 |
| Total Debt/Equity | 0.08 |
| Current Ratio | 4.62 |
| Book Value Per Share | 6,050.19 |
| 52-Week Change | -28.66 |
| 52-Week High | 15.15 |
| 52-Week Low | 2.33 |
| Moving Average 50 Days | 4.38 |
| Moving Average 200 Days | 4.05 |
| Average Volume | 129,772 |
| Shares Outstanding | 1.33M |
| % Held by Institutions | 9.2 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | January 09, 2024 |